This is a Validated Antibody Database (VAD) review about mouse Prkar1b, based on 12 published articles (read how Labome selects the articles), using Prkar1b antibody in all methods. It is aimed to help Labome visitors find the most suited Prkar1b antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Prkar1b synonym: AI385716; RIbeta

R&D Systems
domestic sheep polyclonal
  • western blot; human; 1:500; loading ...; fig 4c
In order to elucidate the mechanisms by which ARHGAP36 blocks protein kinase A signaling, R&D Systems Prkar1b antibody (R&D Systems, AF4177) was used in western blot on human samples at 1:500 (fig 4c). Nat Commun (2016) ncbi
domestic sheep polyclonal
  • western blot; rat; 1:500; fig 1
  • western blot; human; 1:500; fig 2
R&D Systems Prkar1b antibody (R&D Systems, AF4177) was used in western blot on rat samples at 1:500 (fig 1) and in western blot on human samples at 1:500 (fig 2). Mol Med Rep (2016) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig s2a
Invitrogen Prkar1b antibody (Thermo Fisher, PA5-13798) was used in western blot on rat samples at 1:1000 (fig s2a). Aging Cell (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5l
Cell Signaling Technology Prkar1b antibody (CST, 9378S) was used in western blot on human samples at 1:1000 (fig 5l). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology Prkar1b antibody (Cell Signaling, 9371) was used in western blot on human samples at 1:1000 (fig 2a). Oncogene (2019) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology Prkar1b antibody (Cell Signaling, 9371) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Prkar1b antibody (CST, 9371) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4d
In order to investigate the interaction between GRAF1 and RAB8, Cell Signaling Technology Prkar1b antibody (Cell Signaling, 9378) was used in western blot on human samples at 1:1000 (fig 4d). J Cell Sci (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Prkar1b antibody (Cell Signaling Technology, 9371) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2
In order to analyze the participation in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes by NMDA receptors, Cell Signaling Technology Prkar1b antibody (Cell Signaling, 9371) was used in western blot on mouse samples at 1:1000 (fig 2). J Pathol (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 6
In order to determine the involvement of the CXCL12 system in adapting skeletal muscles to physical exercise, Cell Signaling Technology Prkar1b antibody (Cell Signaling Technology, 9378) was used in western blot on rat samples at 1:1000 (fig 6). Cell Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology Prkar1b antibody (Cell Signaling Technology, 9378) was used in western blot on mouse samples at 1:1000 (fig 5). Cell Rep (2016) ncbi
Articles Reviewed
  1. Qin Y, Chen W, Jiang G, Zhou L, Yang X, Li H, et al. Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer. Sci Adv. 2020;6:eaaw9960 pubmed publisher
  2. Ye J, Yin Y, Liu H, Fang L, Tao X, Wei L, et al. Tau inhibits PKA by nuclear proteasome-dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation. Aging Cell. 2020;19:e13055 pubmed publisher
  3. Zhang M, Suarez E, Vasquez J, Nathanson L, Peterson L, Rajapakshe K, et al. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity. Oncogene. 2019;38:1121-1135 pubmed publisher
  4. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  5. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  6. Vidal Quadras M, Holst M, Francis M, Larsson E, Hachimi M, Yau W, et al. Endocytic turnover of Rab8 controls cell polarization. J Cell Sci. 2017;130:1147-1157 pubmed publisher
  7. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  8. Eccles R, Czajkowski M, Barth C, Müller P, McShane E, Grunwald S, et al. Bimodal antagonism of PKA signalling by ARHGAP36. Nat Commun. 2016;7:12963 pubmed publisher
  9. Shen J, Wang R, He Z, Huang H, He X, Zhou J, et al. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes. J Pathol. 2016;240:149-60 pubmed publisher
  10. Feng G, Yan Z, Li C, Hou Y. microRNA-208a in an early stage myocardial infarction rat model and the effect on cAMP-PKA signaling pathway. Mol Med Rep. 2016;14:1631-5 pubmed publisher
  11. Puchert M, Adams V, Linke A, Engele J. Evidence for the involvement of the CXCL12 system in the adaptation of skeletal muscles to physical exercise. Cell Signal. 2016;28:1205-15 pubmed publisher
  12. Najibi M, Labed S, Visvikis O, IRAZOQUI J. An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense. Cell Rep. 2016;15:1728-42 pubmed publisher